The NHS is launching a search for nearly 150,000 volunteers to take part in a series of research trials that could transform cancer treatment. Three cancer projects have been selected as part of the ...

InhaleRX Ltd (ASX:IRX) – a company which develops inhaled drug-device treatments for pain management and a range of mental ...

Most discontinued anti-tau antibodies (red) targeted tau’s N-terminus. Of the antibodies currently in trials (green), bepranemab and E2814 presented results at CTAD, while JJ-63733657/posdinemab and ...

An international, multidisciplinary team of leading neuro-oncology researchers and clinicians has released new ...

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...

Real-world results may differ from those seen in clinical trials for CAR T-cell therapy and bispecific antibodies for the ...

The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

Tivic Health Systems (Nasdaq:TIVC) announced today that it completed enrollment in a study for its vagus nerve stimulation (VNS) device.